Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (31-40 of 281) with videos related to

Pageof 29
Sort By:
Journal of Scleroderma and Related Disorders|April 6, 2022
Small intestinal bacterial overgrowth in systemic sclerosisKathleen Morrisroe, Murray Baron, Tracy Frech, et al.
The Journal of Rheumatology|December 17, 2010
Disability in systemic sclerosis -- a longitudinal observational studyMireille Schnitzer, Marie Hudson, Murray Baron, et al.
Arthritis Research & Therapy|June 7, 2020
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)Boyang Zheng, Marie Hudson, Mianbo Wang, et al.
The Journal of Rheumatology|July 5, 2011
Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosisMurray Baron, Marie Hudson, Russell Steele, et al.
Arthritis Care & Research|April 1, 2011
Modeling smoking in systemic sclerosis: a comparison of different statistical approachesMarie Hudson, Ernest Lo, Murray Baron, et al.
Rheumatology International|December 7, 2010
Corticosteroids and the risk of scleroderma renal crisis: a systematic reviewGerald Trang, Russell Steele, Murray Baron, et al.
Gastroenterology & Hepatology|March 14, 2017
Hepatic Overlap Syndrome Improved With InfliximabNir Hilzenrat, Esther Lamoureux, Albert Cohen, et al.
The Journal of Rheumatology|August 4, 2005
Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarctionMarie Hudson, Murray Baron, Elham Rahme, et al.
Arthritis Care & Research|January 4, 2012
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosisRussell Steele, Marie Hudson, Ernest Lo, et al.
International Journal of Rheumatic Diseases|October 9, 2025
The PROMIS-29 and SF-36 Quality of Life Scales Are Not Interchangeable in Systemic SclerosisMurray Baron, Charmaine van Eeden, Mohamed Osman, et al.
Pageof 29

Showing results (31-40 of 281) with videos related to

Sort By:
Pageof 29
Journal of Scleroderma and Related Disorders|April 6, 2022
Small intestinal bacterial overgrowth in systemic sclerosisKathleen Morrisroe, Murray Baron, Tracy Frech, et al.
The Journal of Rheumatology|December 17, 2010
Disability in systemic sclerosis -- a longitudinal observational studyMireille Schnitzer, Marie Hudson, Murray Baron, et al.
Arthritis Research & Therapy|June 7, 2020
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)Boyang Zheng, Marie Hudson, Mianbo Wang, et al.
The Journal of Rheumatology|July 5, 2011
Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosisMurray Baron, Marie Hudson, Russell Steele, et al.
Arthritis Care & Research|April 1, 2011
Modeling smoking in systemic sclerosis: a comparison of different statistical approachesMarie Hudson, Ernest Lo, Murray Baron, et al.
Rheumatology International|December 7, 2010
Corticosteroids and the risk of scleroderma renal crisis: a systematic reviewGerald Trang, Russell Steele, Murray Baron, et al.
Gastroenterology & Hepatology|March 14, 2017
Hepatic Overlap Syndrome Improved With InfliximabNir Hilzenrat, Esther Lamoureux, Albert Cohen, et al.
The Journal of Rheumatology|August 4, 2005
Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarctionMarie Hudson, Murray Baron, Elham Rahme, et al.
Arthritis Care & Research|January 4, 2012
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosisRussell Steele, Marie Hudson, Ernest Lo, et al.
International Journal of Rheumatic Diseases|October 9, 2025
The PROMIS-29 and SF-36 Quality of Life Scales Are Not Interchangeable in Systemic SclerosisMurray Baron, Charmaine van Eeden, Mohamed Osman, et al.
Pageof 29